B. Riley Begins Coverage of Electromed with Buy Rating

Stock analysts from B. Riley have recently started coverage on Electromed (NYSE:ELMD). In a research note published on Thursday, they assigned a "buy" rating for the company along with a price target of $38.00 per share. This target indicates a potential upside of approximately 29.43% from Electromed's current share price.

In a separate report, StockNews.com downgraded Electromed from a "strong-buy" to a "buy" rating on Wednesday.

Electromed Stock Performance Overview

On Thursday, Electromed's stock opened at $29.36. Over the past year, the stock has fluctuated significantly, hitting a low of $13.74 and a high of $35.56. Currently, the company has a market capitalization of $251.32 million, a price-to-earnings (PE) ratio of 39.15, and a beta value of 0.33. The stock has a 50-day moving average price of $31.40 and a 200-day moving average price of $25.15.

Insider Transactions at Electromed

In related news, Kathleen Skarvan, a director at Electromed, sold 38,954 shares of the company's stock on February 18th at an average price of $29.28 each, which amounted to a total sale of $1,140,573.12. Post-transaction, she holds 32,622 shares valued at approximately $955,172.16, representing a 54.42% decrease in her ownership. Additionally, Andrew Summers, another director, sold 17,463 shares on December 2nd at an average price of $30.09, totaling $525,461.67. After this sale, he retains 189,838 shares valued at around $5,712,225.42, reflecting an 8.42% decrease in his ownership. Over the last three months, insiders have sold a total of 77,788 shares valued at $2,326,350, and currently, 14.00% of Electromed's stock is owned by insiders.

Institutional Investor Activities

Recent activity from institutional investors shows varied interest in Electromed. In the fourth quarter, Russell Investments Group Ltd. initiated a new position in the company valued at $37,000. Similarly, IFP Advisors Inc. acquired shares worth approximately $59,000. Quantbot Technologies LP purchased a new stake valued at around $99,000. Bank of America Corp DE increased its holdings by 179.2%, now owning 4,004 shares valued at $118,000, following an acquisition of an additional 2,570 shares. Point72 Asia Singapore Pte. Ltd. also joined in buying shares worth approximately $119,000. Currently, around 40.82% of Electromed’s stock is held by institutional investors and hedge funds.

About Electromed, Inc.

Electromed, Inc. specializes in developing, manufacturing, marketing, and selling airway clearance therapy and related products. The company focuses on high-frequency chest wall oscillation (HFCWO) therapy, which is beneficial for patients with pulmonary issues, including those with bronchiectasis, cystic fibrosis, and various neuromuscular conditions. Their product offerings include the SmartVest airway clearance system, the SmartVest SQL System, and the SmartVest Clearway System, which are designed to enhance respiratory health for patients of all ages. They also offer SmartVest Connect, a wireless technology that facilitates data sharing between patients and physicians to improve treatment outcomes.

stocks, investment, analysis